Skip to Content
Merck
  • Nestin expression and reactive phenomena in the mouse cochlea after kanamycin ototoxicity.

Nestin expression and reactive phenomena in the mouse cochlea after kanamycin ototoxicity.

The European journal of neuroscience (2014-04-03)
Tiziana Martone, Pamela Giordano, Federico Dagna, Daniela Carulli, Roberto Albera, Ferdinando Rossi
ABSTRACT

Following injury to the adult mammalian cochlea, hair cells cannot be spontaneously replaced. Nonetheless, the postnatal cochlea contains progenitor cells, distinguished by the expression of nestin, which are able to proliferate and form neurospheres in vitro. Such resident progenitors might be endowed with reparative potential. However, to date little is known about their behaviour in situ following hair cell injury. Using adult mice and ex vivo cochlear cultures, we sought to determine whether: (i) resident cochlear progenitors respond to kanamycin ototoxicity and compensate for it; and (ii) the reparative potential of cochlear progenitors can be stimulated by the addition of growth factors. Morphological changes of cochlear tissue, expression of nestin mRNA and protein and cell proliferation were investigated in these models. Our observations show that ototoxic injury has modest effects on nestin expression and cell proliferation. On the other hand, the addition of growth factors to the injured cochlear explants induced the appearance of nestin-positive cells in the supporting cell area of the organ of Corti. The vast majority of nestin-expressing cells, however, were not proliferating. Growth factors also had a robust stimulatory effect on axonal sprouting and the proliferative response, which was more pronounced in injured cochleae. On the whole, our findings indicate that nestin expression after kanamycin ototoxicity is related to tissue reactivity rather than activation of resident progenitors attempting to replace the lost receptors. In addition, administration of growth factors significantly enhances tissue remodelling, suggesting that cochlear repair may be promoted by the exogenous application of regeneration-promoting substances.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-SOX2 antibody produced in rabbit
Sigma-Aldrich
Fluorescein isothiocyanate isomer I, ≥97.5% (HPLC)
Sigma-Aldrich
Fluorescein isothiocyanate isomer I, suitable for protein labeling, ≥90% (HPLC), powder
Sigma-Aldrich
Fluorescein isothiocyanate isomer I, ≥97.5% (HPLC)
Sigma-Aldrich
Xylazine, ≥99%
Sigma-Aldrich
Ampicillin, meets USP testing specifications
Sigma-Aldrich
Anti-SOX2 antibody produced in rabbit, IgG fraction of antiserum
Sigma-Aldrich
Anti-sox2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-Nestin Antibody, clone rat-401, clone rat-401, Chemicon®, from mouse
Sigma-Aldrich
Anti-Neurofilament H Antibody, Chemicon®, from chicken
Sigma-Aldrich
Anti-Sox2 Antibody, Chemicon®, from rabbit
Sigma-Aldrich
Fluorescein 5(6)-isothiocyanate, ≥90% (HPLC)
Sigma-Aldrich
β-D-Allose, rare aldohexose sugar
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Ampicillin, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
Fluorescein 5(6)-isothiocyanate, BioReagent, suitable for fluorescence, mixture of 2 components, ≥90% (HPLC)
Ampicillin, anhydrous, European Pharmacopoeia (EP) Reference Standard
Supelco
Ampicillin, analytical standard
USP
Ampicillin, United States Pharmacopeia (USP) Reference Standard